D.A. Davidson & CO. Has $2.18 Million Position in The Allstate Corporation (NYSE:ALL)

D.A. Davidson & CO. decreased its position in The Allstate Corporation (NYSE:ALL - Free Report) by 17.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,513 shares of the insurance provider's stock after selling 2,230 shares during the quarter. D.A. Davidson & CO.'s holdings in Allstate were worth $2,177,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in Allstate by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 32,635,424 shares of the insurance provider's stock worth $6,291,783,000 after buying an additional 389,426 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of Allstate by 2.4% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,334,926 shares of the insurance provider's stock valued at $1,799,681,000 after purchasing an additional 218,771 shares in the last quarter. Bank of America Corp DE boosted its stake in shares of Allstate by 157.9% during the 4th quarter. Bank of America Corp DE now owns 6,591,138 shares of the insurance provider's stock valued at $1,270,705,000 after buying an additional 4,035,629 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Allstate by 3.1% during the fourth quarter. Geode Capital Management LLC now owns 6,419,728 shares of the insurance provider's stock worth $1,236,060,000 after buying an additional 191,147 shares in the last quarter. Finally, GQG Partners LLC increased its stake in shares of Allstate by 64.1% in the fourth quarter. GQG Partners LLC now owns 4,316,516 shares of the insurance provider's stock worth $832,181,000 after buying an additional 1,685,694 shares during the last quarter. Hedge funds and other institutional investors own 76.47% of the company's stock.

Allstate Trading Down 1.8%

ALL traded down $3.54 during trading on Monday, reaching $194.46. The company had a trading volume of 1,597,819 shares, compared to its average volume of 1,636,393. The firm's 50-day simple moving average is $201.37 and its 200 day simple moving average is $196.70. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.40 and a current ratio of 0.40. The company has a market cap of $51.50 billion, a price-to-earnings ratio of 13.28, a PEG ratio of 1.03 and a beta of 0.33. The Allstate Corporation has a 12-month low of $158.04 and a 12-month high of $213.18.

Allstate (NYSE:ALL - Get Free Report) last posted its earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.98 by ($0.45). Allstate had a net margin of 6.19% and a return on equity of 24.62%. The business had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. During the same quarter last year, the firm earned $5.13 earnings per share. Allstate's revenue was up 7.8% compared to the same quarter last year. Equities research analysts anticipate that The Allstate Corporation will post 18.74 earnings per share for the current year.

Allstate Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, July 1st. Stockholders of record on Monday, June 9th were paid a dividend of $1.00 per share. The ex-dividend date was Monday, June 9th. This represents a $4.00 annualized dividend and a dividend yield of 2.06%. Allstate's dividend payout ratio (DPR) is presently 27.32%.

Wall Street Analysts Forecast Growth

ALL has been the topic of several research analyst reports. Raymond James Financial reaffirmed a "strong-buy" rating and set a $250.00 price target (up previously from $240.00) on shares of Allstate in a research report on Monday, May 5th. Wells Fargo & Company reduced their price objective on Allstate from $200.00 to $197.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. BMO Capital Markets reiterated an "outperform" rating on shares of Allstate in a research note on Friday, May 16th. Wall Street Zen upgraded shares of Allstate from a "hold" rating to a "buy" rating in a research report on Thursday, May 1st. Finally, Evercore ISI boosted their price objective on shares of Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $226.27.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.